Octagon Capital Advisors LP Immunovant, Inc. Transaction History

Octagon Capital Advisors LP

  • $414 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$31.31 - $44.19 $8.56 Million - $12.1 Million
273,289 New
273,289 $11.5 Million
Q2 2022

Aug 15, 2022
SELL
$3.38 - $5.65 $3.03 Million - $5.06 Million
-895,939 Reduced 60.74%
579,061 $2.26 Million
Q1 2022

May 16, 2022
BUY
$5.06 - $8.77 $4.56 Million - $7.91 Million
902,138 Added 157.48%
1,475,000 $8.13 Million
Q4 2021

Feb 14, 2022
BUY
$7.33 - $9.32 $4.2 Million - $5.34 Million
572,862 New
572,862 $4.88 Million

Others Institutions Holding IMVT

# of Institutions
211
Shares Held
66.9M
Call Options Held
2.3M
Put Options Held
631K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Octagon Capital Advisors LP Portfolio

Follow Octagon Capital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Octagon Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Octagon Capital Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email